Dr Reddy’s, Alvotech partner to develop and commercialize biosimilar of cancer drug Keytruda

By ihub_admin, 6 June, 2025
Highlight

Dr Reddy’s Laboratories announced that it has partnered with Alvotech, to co-develop, manufacture, and sell a biosimilar version of Keytruda (pembrolizumab), for global markets.